Telos Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.57M | Buy |
19,242
+1,068
| +6% | +$475K | 0.87% | 36 |
|
|
2025
Q1 | $8.81M | Buy |
18,174
+547
| +3% | +$265K | 0.96% | 30 |
|
|
2024
Q4 | $7.1M | Buy |
17,627
+1,605
| +10% | +$646K | 0.76% | 44 |
|
|
2024
Q3 | $7.45M | Buy |
16,022
+6
| +0% | +$2.79K | 0.78% | 43 |
|
|
2024
Q2 | $7.51M | Buy |
16,016
+546
| +4% | +$256K | 0.83% | 38 |
|
|
2024
Q1 | $6.47M | Buy |
15,470
+397
| +3% | +$166K | 0.73% | 45 |
|
|
2023
Q4 | $6.13M | Buy |
15,073
+237
| +2% | +$96.4K | 0.75% | 44 |
|
|
2023
Q3 | $5.16M | Sell |
14,836
-90
| -0.6% | -$31.3K | 0.72% | 45 |
|
|
2023
Q2 | $5.25M | Sell |
14,926
-333
| -2% | -$117K | 0.7% | 50 |
|
|
2023
Q1 | $4.81M | Sell |
15,259
-841
| -5% | -$265K | 0.67% | 59 |
|
|
2022
Q4 | $4.65M | Sell |
16,100
-43
| -0.3% | -$12.4K | 0.68% | 57 |
|
|
2022
Q3 | $4.67M | Sell |
16,143
-622
| -4% | -$180K | 0.77% | 46 |
|
|
2022
Q2 | $4.72M | Sell |
16,765
-175
| -1% | -$49.3K | 0.72% | 49 |
|
|
2022
Q1 | $4.42M | Sell |
16,940
-159
| -0.9% | -$41.5K | 0.57% | 64 |
|
|
2021
Q4 | $3.76M | Buy |
17,099
+581
| +4% | +$128K | 0.47% | 72 |
|
|
2021
Q3 | $3M | Buy |
16,518
+1,156
| +8% | +$210K | 0.41% | 80 |
|
|
2021
Q2 | $3.1M | Buy |
+15,362
| New | +$3.1M | 0.41% | 80 |
|